Scarlet red

DB19136ApprovedWithdrawnSmall molecule

Scarlet red is under investigation in clinical trial NCT00591916 (New Treatment for Donor Sites).

Chemical structure of Scarlet red
Formula / weight
C24H20N4O · 380.451 g/mol (avg)
First approval
Canada, 2002
Also known as
1-((2-methyl-4-((2-methylphenyl)azo)phenyl)azo)-2-naphthalenol · 2-naphthalenol, 1-((2-methyl-4-((2-methylphenyl)azo)phenyl)azo)- · 2-naphthol, 1-(4-o-tolylazo-o-tolylazo)- · 2',3-dimethyl-4-(2-hydroxynaphthylazo) azobenzene · C.i. solvent red 24
Code names
AKA501 · CI-26105 · NSC-10472

Resolves to

Compound
UNIII35E9QU96CCAS85-83-6ChEMBLCHEMBL1707454KEGGC19520
Clinical / RWD
RxNorm36224
Structure
InChIKeyRCTGMCJBQGBLKT-PAMTUDGESA-NSMILESCC1=CC=CC=C1\N=N\C1=CC=C(\N=N\C2=C(O)C=CC3=CC=CC=C23)C(C)=C1
Targets
P04040CAT

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Scarlet red, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In